News | 10 June 2012
MUMBAI: Indian pharmaceutical companies need to go for aggressive research and patent filing like China and Japan and unless spending on R&D is scaled up, it would be difficult to create new molecules, industry experts said. "Our Indian companies are ...
Click on the link to read the full article at Economic Times
(This link will open in a new window)